Article
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
Oncotarget - 8 Dec 2015
Pasello Giulia, Urso Loredana, Mencoboni Manlio, Grosso Federica, Ceresoli Giovanni Luca, Lunardi Francesca, Vuljan Stefania Edith, Bertorelle Roberta, Sacchetto Valeria, Ciminale Vincenzo, Rea Federico, Favaretto Adolfo, Conte PierFranco, Calabrese Fiorella
Abstract excerpt
Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited treatment options. Sarcomatoid/biphasic mesotheliomas are characterized by more aggressive behaviour and a poorer prognosis compared with the epithelioid subtype. To date prognostic and tailored therapeutic biomarkers are lacking. The present study analyzed the expression levels of MDM2 and HIF1alpha in different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
